ORGANIC Farma Zdrowia S.A. (WSE:ORG)
Poland
· Delayed Price · Currency is PLN 9.00
0.00 (0.00%)
At close: Jun 13, 2025
ORGANIC Farma Zdrowia Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 122.36 | 121.06 | 109.89 | 102.9 | 100.28 | 102.7 | Upgrade
|
| Revenue Growth (YoY) | 7.90% | 10.17% | 6.79% | 2.62% | -2.35% | 2.68% | Upgrade
|
| Cost of Revenue | 77.1 | 76.29 | 71.39 | 70.75 | 67.7 | 68.26 | Upgrade
|
| Gross Profit | 45.27 | 44.77 | 38.49 | 32.16 | 32.58 | 34.44 | Upgrade
|
| Selling, General & Admin | 39.31 | 38.69 | 34.41 | 33.74 | 34.97 | 33.6 | Upgrade
|
| Other Operating Expenses | 2.13 | 1.92 | 1.92 | 0.52 | 4.86 | 1.42 | Upgrade
|
| Operating Expenses | 43.03 | 42.2 | 38 | 36.19 | 43.04 | 38.28 | Upgrade
|
| Operating Income | 2.24 | 2.57 | 0.49 | -4.03 | -10.46 | -3.85 | Upgrade
|
| Interest Expense | -0.34 | -0.34 | -0.53 | -0.46 | -0.3 | -0.34 | Upgrade
|
| Interest & Investment Income | 0.02 | 0.01 | 0.01 | 0.18 | 0.53 | 0.26 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | 0.1 | 0.99 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.06 | -0.11 | 6.43 | -0.46 | 0.01 | -1.91 | Upgrade
|
| EBT Excluding Unusual Items | 1.86 | 2.12 | 6.41 | -4.78 | -10.11 | -4.84 | Upgrade
|
| Impairment of Goodwill | -0.12 | -0.12 | -0.12 | -0.12 | -0.12 | -0.12 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 1.84 | 4.06 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.01 | -0.02 | 0.02 | -0.03 | -0.52 | -0.02 | Upgrade
|
| Asset Writedown | -0.14 | -0.14 | -0.02 | -0.21 | -2.87 | -0.24 | Upgrade
|
| Other Unusual Items | 0.26 | 0.26 | - | - | - | - | Upgrade
|
| Pretax Income | 1.87 | 2.11 | 8.12 | -1.07 | -13.62 | -5.22 | Upgrade
|
| Income Tax Expense | 0.49 | 0.49 | 0.69 | 0 | 0.03 | 0.11 | Upgrade
|
| Net Income | 1.38 | 1.61 | 7.43 | -1.08 | -13.65 | -5.33 | Upgrade
|
| Net Income to Common | 1.38 | 1.61 | 7.43 | -1.08 | -13.65 | -5.33 | Upgrade
|
| Net Income Growth | -84.07% | -78.30% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 5 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 12.69% | 8.96% | Upgrade
|
| EPS (Basic) | 0.25 | 0.29 | 1.35 | -0.20 | -2.48 | -1.09 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.29 | 1.35 | -0.20 | -2.48 | -1.09 | Upgrade
|
| EPS Growth | -84.07% | -78.30% | - | - | - | - | Upgrade
|
| Free Cash Flow | 0.48 | 0.54 | -0.27 | -4.56 | -5.73 | -2.87 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.10 | -0.05 | -0.83 | -1.04 | -0.59 | Upgrade
|
| Gross Margin | 36.99% | 36.98% | 35.03% | 31.25% | 32.49% | 33.53% | Upgrade
|
| Operating Margin | 1.83% | 2.12% | 0.45% | -3.92% | -10.43% | -3.75% | Upgrade
|
| Profit Margin | 1.13% | 1.33% | 6.76% | -1.05% | -13.61% | -5.19% | Upgrade
|
| Free Cash Flow Margin | 0.39% | 0.44% | -0.25% | -4.43% | -5.71% | -2.79% | Upgrade
|
| EBITDA | 3.88 | 4.16 | 2.16 | -1.98 | -7.13 | -0.47 | Upgrade
|
| EBITDA Margin | 3.17% | 3.43% | 1.97% | -1.92% | -7.11% | -0.46% | Upgrade
|
| D&A For EBITDA | 1.64 | 1.59 | 1.67 | 2.05 | 3.33 | 3.38 | Upgrade
|
| EBIT | 2.24 | 2.57 | 0.49 | -4.03 | -10.46 | -3.85 | Upgrade
|
| EBIT Margin | 1.83% | 2.12% | 0.45% | -3.92% | -10.43% | -3.75% | Upgrade
|
| Effective Tax Rate | 26.02% | 23.47% | 8.49% | - | - | - | Upgrade
|
| Revenue as Reported | 122.36 | 121.06 | 109.89 | 102.9 | 100.28 | 102.7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.